LLOY:LSE

Lloyds Banking Group plc

Data as of 2026-03-10 - not real-time

£95.16

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

LLOY is trading at 95.16p, below its 20‑day SMA of 101.22p and 50‑day SMA of 102.31p, indicating short‑term weakness. However the 200‑day SMA sits at 88.34p, so the price remains comfortably above long‑term trend. The RSI of 34.7 suggests the stock is in oversold territory, while the MACD histogram is negative, confirming bearish momentum in the near term. Volatility over the past 30 days is high at about 32 % and the beta of 0.38 points to low systematic risk relative to the market. The forward PE of 8.0× is well below the sector average of 17.4×, and the current PE of 13.6× also signals cheap earnings. The dividend yield of 3.8 % with a payout ratio under 50 % provides attractive income, and the recent £1.75 bn share‑buyback programme adds further upside potential.
Analysts project a mean target of 111.6p (median 118.5p), implying roughly a 17 % upside, and the fear‑and‑greed index sits in “Extreme Greed,” suggesting bullish sentiment. Strong revenue growth of 14 % and operating margins above 40 % underpin earnings momentum, although operating cash flow is negative, a point to monitor. The balance sheet is net‑cash positive (cash exceeds debt), reducing financial risk. Given the mix of cheap valuation, solid dividend, and upcoming buyback, the stock appears **undervalued** with a **blend** of growth and value attributes.

Trading Recommendations

Short Term

< 1 year
buy
Conviction: 7/10

Key Factors

  • Share buyback programme adds near‑term price support
  • Price near technical support level (92.36p)
  • High dividend yield with sustainable payout

Medium Term

1–3 years
buy
Conviction: 8/10

Key Factors

  • Forward PE of 8× indicates strong earnings upside
  • Revenue growth of 14% and high operating margins
  • Target price median of 118.5p suggests ~24% upside

Long Term

> 3 years
hold
Conviction: 6/10

Key Factors

  • Net‑cash position reduces financial risk
  • Regulatory environment for UK banks remains uncertain
  • Attractive dividend yield supports total return

Key Metrics & Analysis

Financial Health

Revenue Growth14.40%
Profit Margin25.01%
P/E Ratio13.6
ROE10.15%
ROA0.51%
P/B Ratio134.0
Op. Cash Flow£-7781000192
Industry P/E17.4

Technical Analysis

TrendNeutral
RSI34.7
Support£92.36
Resistance£106.85
MA 20£101.22
MA 50£102.31
MA 200£88.34
MACDBearish
VolumeStable
Fear & Greed Index75.89

Valuation

Target Price£111.61
Upside/Downside17.29%
GradeUndervalued
TypeBlend
Dividend Yield3.83%

Risk Assessment

Beta0.38
Volatility31.69%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies. Not financial advice. Always do your own research before making any investment decisions.